Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C SWANTON

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
ESMO Open|September 5, 2025
Toxicity and efficacy of antibody-drug conjugates in advanced solid tumors: a retrospective single-center analysis of clinical trialsR Woodford, H Almarzouq, N Beygozlu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
The future of UK healthcare: problems and potential solutions to a system in crisisH E Montgomery, A Haines, N Marlow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanomaE Ghorani, R Rosenthal, N McGranahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2018
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolutionS Venkatesan, R Rosenthal, N Kanu, et al.
British Journal of Cancer|July 29, 2010
A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unitA T Brunetto, D Sarker, D Papadatos-Pastos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2015
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancerG Middleton, L R Crack, S Popat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2024
Oncogenic extrachromosomal DNA identification using whole-genome sequencing from formalin-fixed glioblastomasI Noorani, J Luebeck, A Rowan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurementJ Budczies, M Allgäuer, K Litchfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementH A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2016
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancerM Jamal-Hanjani, G A Wilson, S Horswell, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
ESMO Open|September 5, 2025
Toxicity and efficacy of antibody-drug conjugates in advanced solid tumors: a retrospective single-center analysis of clinical trialsR Woodford, H Almarzouq, N Beygozlu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
The future of UK healthcare: problems and potential solutions to a system in crisisH E Montgomery, A Haines, N Marlow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanomaE Ghorani, R Rosenthal, N McGranahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2018
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolutionS Venkatesan, R Rosenthal, N Kanu, et al.
British Journal of Cancer|July 29, 2010
A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unitA T Brunetto, D Sarker, D Papadatos-Pastos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2015
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancerG Middleton, L R Crack, S Popat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2024
Oncogenic extrachromosomal DNA identification using whole-genome sequencing from formalin-fixed glioblastomasI Noorani, J Luebeck, A Rowan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurementJ Budczies, M Allgäuer, K Litchfield, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementH A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2016
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancerM Jamal-Hanjani, G A Wilson, S Horswell, et al.
Pageof 7